Effectiveness of Statins for Oxaliplatin‐Induced Peripheral Neuropathy: A Multicenter Retrospective Observational Study

Documenti analoghi

• Evaluation of Interstitial Lung Disease Complications Caused by Biologic Agents Using a Spontaneous Adverse Drug Reaction Reporting Database
  di: Ayu Minagi, et al.
  Pubblicazione: (2025)
• Response to Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
  di: Keisuke Mine, et al.
  Pubblicazione: (2025)
• Muscle Atrophy‐Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase Data
  di: Shiho Ueta, et al.
  Pubblicazione: (2026)
• Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell‐Derived Cardiomyocytes and FDA Adverse Events Reporting System
  di: Shota Yanagida, et al.
  Pubblicazione: (2025)
• Minimal Sufficient Views: A DNN model making predictions with more evidence has higher accuracy
  di: Kawano, Keisuke, et al.
  Pubblicazione: (2024)